CNBC Pro

Citi downgrades Merck to neutral, says drug pipeline struggles will hold stock back

Medicine pill is seen with Merck logo displayed on a screen in the background in this illustration photo taken in Poland on October 4, 2021.
NurPhoto | NurPhoto | Getty Images

Disappointing results for some major drugs has limited the upside for Merck's stock, according to Citi.

More In Street Calls

CNBC ProJPMorgan upgrades Cigna, says insurer is undervalued and pays nice dividend
CNBC ProBank of America says it's time to buy this electric vehicle stock as sales improve
CNBC ProHere are Monday's biggest analyst calls: Tesla, SoFi, Target, Netflix, Boeing, Cigna, Nio & more